the response from experts is mixed
- Written by: Paul Liknaitzky, Head of Clinical Psychedelic Research, Monash University
Collaborative care teams will need to be established for safe treatment.Author providedA few days ago, the Australian drug regulator – the Therapeutic Goods Administration (TGA) – surprised experts around the world when it announced the approval of certain psychedelic treatments.
From July this year, the TGA will permit authorised...